Revolution Medicines (RVMD)
(Delayed Data from NSDQ)
$37.11 USD
+1.15 (3.20%)
Updated Apr 29, 2024 04:00 PM ET
After-Market: $37.12 +0.01 (0.03%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth D Momentum F VGM
Earnings News For RVMD
-
Revolution Medicines, Inc. (RVMD) Reports Q4 Loss, Lags Revenue Estimates
-
Revolution Medicines Reports Fourth Quarter and Full Year 2023 Financial Results and Update on Corporate Progress
-
Revolution Medicines, Inc. (RVMD) Reports Q3 Loss, Lags Revenue Estimates
-
Revolution Medicines Reports Third Quarter 2023 Financial Results and Update on Corporate Progress
-
Revolution Medicines, Inc. (RVMD) Reports Q2 Loss, Misses Revenue Estimates
-
Revolution Medicines Reports Second Quarter 2023 Financial Results and Update on Corporate Progress
-
Revolution Medicines, Inc. (RVMD) Reports Q1 Loss, Tops Revenue Estimates
-
Revolution Medicines Reports First Quarter 2023 Financial Results and Update on Corporate Progress
-
Revolution Medicines, Inc. (RVMD) Expected to Beat Earnings Estimates: Should You Buy?
-
Revolution Medicines, Inc. (RVMD) Reports Q4 Loss, Tops Revenue Estimates
-
Revolution Medicines Reports Fourth Quarter and Full Year 2022 Financial Results and Update on Corporate Progress
-
Revolution Medicines, Inc. (RVMD) Reports Q3 Loss, Misses Revenue Estimates
-
Revolution Medicines Reports Third Quarter 2022 Financial Results and Update on Corporate Progress
-
Revolution Medicines, Inc. (RVMD) Reports Q2 Loss, Tops Revenue Estimates
-
Revolution Medicines, Inc. (RVMD) Reports Q1 Loss, Misses Revenue Estimates
-
Revolution Medicines, Inc. (RVMD) Reports Q4 Loss, Tops Revenue Estimates
-
Revolution Medicines, Inc. (RVMD) Reports Q3 Loss, Lags Revenue Estimates
-
Earnings Preview: Revolution Medicines, Inc. (RVMD) Q3 Earnings Expected to Decline
-
Revolution Medicines, Inc. (RVMD) Reports Q2 Loss, Misses Revenue Estimates
-
Earnings Preview: Revolution Medicines, Inc. (RVMD) Q2 Earnings Expected to Decline
-
Revolution Medicines, Inc. (RVMD) Reports Q1 Loss, Tops Revenue Estimates
-
Revolution Medicines, Inc. (RVMD) May Report Negative Earnings: Know the Trend Ahead of Q1 Release